Key Takeaways
While both contain semaglutide, Wegovy is approved specifically for weight management, whereas Ozempic is approved for the treatment of type 2 diabetes.
Because Wegovy is administered at higher doses than Ozempic, it tends to produce greater weight loss—but also carries a higher likelihood of gastrointestinal side effects.
Choosing between them depends heavily on individual factors such as medical conditions (like diabetes), cost or insurance coverage, and how well the drug is tolerated
Ozempic and Wegovy both contain semaglutide and work as glucagon-like peptide-1 (GLP-1) receptor agonists, though they have different Food and Drug Administration (FDA)-approved uses. They also differ in side effects, dosage, cost, and dosage forms.
Key Similarities and Differences
The t